ARGX cites Vision 2030 targets and immunology pipeline progress
Argenx says its Vision 2030 plan targets treating 50,000 patients and 10 diseases, citing strong progress in MG and CIDP and pipeline expansion.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.